Showing results (151-160 of 192) with videos related to

Sort By:
Pageof 20
European Cytokine Network|April 17, 2002
Circulating macrophage colony stimulating factor as a marker of tumour progressionRaymond S McDermott, Laurent Deneux, Véronique Mosseri, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2012
The discovery of aminopyrazines as novel, potent Na(v)1.7 antagonists: hit-to-lead identification and SARHoward Bregman, Hanh Nho Nguyen, Elma Feric, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|April 22, 2008
Physician-based physical activity counseling for middle-aged and older adults: a randomized trialM G Goldstein, B M Pinto, B H Marcus, et al.
Irish Journal of Medical Science|July 14, 2023
Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in IrelandMaha AlSendi, Calvin R Flynn, Muhammad R Khan, et al.
Cancer Research|May 31, 2014
Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitorsSweta Rani, Claire Corcoran, Liam Shiels, et al.
Bioorganic & Medicinal Chemistry Letters|February 10, 2012
Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Na(v)1.7 antagonistsNagasree Chakka, Howie Bregman, Bingfan Du, et al.
Oecologia|June 28, 2018
Temporal records of diet diversity dynamics in individual adult female Steller sea lion (Eumetopias jubatus) vibrissaeA C Doll, B D Taras, C A Stricker, et al.
European Journal of Pharmacology|May 19, 2021
Antitussive effects of NaV 1.7 blockade in Guinea pigsLi Yu, Kojun Tsuji, Izumi Ujihara, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
The acoustic properties, syllable structure, and syllable sequences of ultrasonic vocalizations (USVs) during neonatal opioid withdrawal in FVB/N mouse substrainsKelly K Wingfield, Teodora Misic, Sophia A Miracle, et al.
Therapeutic Advances in Medical Oncology|September 13, 2021
Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label studyRaymond S McDermott, John Greene, John McCaffrey, et al.
Pageof 20